LEADER 01386nam  2200361Ia 450 
001 9910698820303321
005 20090529151556.0
035   $a(CKB)5470000002397666
035   $a(OCoLC)362748388
035   $a(EXLCZ)995470000002397666
100   $a20090529d2001      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $epre-storage leukocyte reduction of whole blood and blood compoments intended for transfusion
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2001]
215   $ai, 22 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 29, 2009).
300   $a"Draft -- not for implementation".
300   $a"January, 2001".
320   $aIncludes bibliographical references (pages 19-22).
517   $aGuidance for industry 
606   $aLeucocyte-poor blood products$xGovernment policy$zUnited States
615  0$aLeucocyte-poor blood products$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698820303321
996   $aGuidance for industry$93434577
997   $aUNINA